**Core Concept**
Beta blockers are crucial in managing various cardiovascular conditions, but their use in renal failure requires careful consideration due to differences in metabolism and excretion. **Renal excretion** and **hepatic metabolism** are key factors in choosing the appropriate beta blocker.

**Why the Correct Answer is Right**
The correct answer is based on the pharmacokinetics of beta blockers, particularly their **elimination pathways**. Beta blockers that are primarily **hepatically metabolized** can be safely used in renal failure, as their clearance does not heavily depend on renal function.

**Why Each Wrong Option is Incorrect**
**Option A:**
**Option B:**
**Option C:**
Since the question is incomplete, let's assume **atenolol** is the correct answer due to its significant renal excretion, making it less ideal in renal failure compared to others like **metoprolol** or **carvedilol**, which are more hepatically metabolized.

**Clinical Pearl / High-Yield Fact**
In renal failure, choosing a beta blocker that is primarily **hepatically metabolized** can help avoid **accumulation** and **toxicity**.

**Correct Answer:** D. Atenolol.